Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Artificial Pancreas Pipeline Market Report Overview
The artificial pancreas helps people with diabetes, primarily type 1, to automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
The artificial pancreas pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The US
· Europe · China · Japan · South Korea |
| Key Regulatory Paths | · PMA
· CE · 510(k) · NMPA · Shonin |
| Leading Companies | · Admetsys Corp
· Advanced Biosensors-Ohio LLC · AiTA Bio Inc · Beta-O2 Technologies Ltd · Bigfoot Biomedical Inc |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Artificial Pancreas Pipeline Market Segmentation by Territories
A few of the key territories with the artificial pancreas pipeline market are the US, Europe, China, Japan, and South Korea. As of September 2024, the US accounted for the highest number of pipeline products.
Artificial Pancreas Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Artificial Pancreas Pipeline Market
Artificial Pancreas Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the artificial pancreas pipeline products market are PMA, CE, 510(k), NMPA, and Shonin. As of September 2024, PMA was the most followed pathway for pipeline products in the artificial pancreas market.
Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Artificial Pancreas Pipeline Market
Artificial Pancreas Pipeline Market – Competitive Landscape
A few of the key companies associated with the artificial pancreas pipeline market are Admetsys Corp, Advanced Biosensors-Ohio LLC, AiTA Bio Inc, Beta-O2 Technologies Ltd, and Bigfoot Biomedical Inc., among others.
Beta-O2 Technologies Ltd: Headquartered in Rosh HaAyin, Israel, it is a biomedical company that develops proprietary implantable bio-artificial pancreas for the treatment of type 1 diabetes. The company’s bio-artificial pancreas is an implantable device that allows for immune isolation of the implanted cells, eliminating the need for frequent insulin injections, glucose measurements, and immunosuppressive therapy. Beta-O2 preclinically tests the bio-artificial adrenal as a treatment for stress disorders.
Bigfoot Biomedical Inc.: It is a medical device company that develops technologies to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. It leverages data, connectivity, automation, and machine learning to automatically and continuously optimize insulin delivery for people with insulin-requiring diabetes and maximize the leverage of healthcare providers. Bigfoot Biomedical provides automated infusion pumps and connected insulin pen options for consumers to meet the needs of a diverse population with insulin-requiring diabetes.
Artificial Pancreas Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Artificial Pancreas Pipeline Market
Segments Covered in the Report
Artificial Pancreas Pipeline Market Territories Outlook (2024)
- The US
- Europe
- China
- Japan
- South Korea
Artificial Pancreas Pipeline Market Regulatory Paths Outlook (2024)
- PMA
- CE
- 510(k)
- NMPA
- Shonin
Scope
This report provides:
- Extensive coverage of the artificial pancreas under development.
- Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
- Reviews of the major players involved in the development of artificial pancreas and lists all their pipeline projects.
- The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of artificial pancreas under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Advanced Biosensors-Ohio LLC
AiTA Bio Inc
Beta Bionics Inc
Beta-O2 Technologies Ltd
Bigfoot Biomedical Inc
BioTex Inc
Captix Biomedical Pty Ltd
Cerco Medical LLC
Children's Hospital of Philadelphia
Converge Biotech, Inc.
Covalor Medical, LLC
De Montfort University
Debiotech SA
Defymed SAS
Diabeloop SA
EOFlow Co Ltd
Giner Inc
Haimai Medical Technology Co Ltd
Harvard John A Paulson School of Engineering and Applied Sciences
Healios Inc
Humacyte Inc
Ideal Medical Technologies Inc
Imperial College London
Indian Institute of Science
Joslin Diabetes Center
Kailian Medical Technology Co Ltd
Kencak LLC
Massachusetts Institute of Technology
McGill University
Medtronic Inc
Medtronic MiniMed Inc
MicroTech Medical Inc
Miromatrix Medical Inc
Modular Medical Inc
Novoculi
Pacific Diabetes Technologies Inc
Pancreum, LLC
PharmaCyte Biotech Inc
Polytechnic University of Valencia
Rensselaer Polytechnic Institute
Senseonics Holdings Inc
SFC Fluidics LLC
Shenzhen Huayuan Regenerative Medicine Co Ltd
Stanford University
TecMed Inc
Thermalin Inc
TypeZero Technologies LLC
U-Needle BV
Universidad Autonoma de Madrid
University of California San Francisco
University of California Santa Barbara
University of Cambridge
University of Florida
University of Minnesota
University of Newcastle
University of Queensland
University of Virginia
ViCentra BV
WaveForm Technologies, Inc
Xeris Biopharma Holdings Inc
Yale University
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the artificial pancreas pipeline market as of September 2024?
As of September 2024, the US accounted for the highest number of pipeline products in the artificial pancreas market.
-
Which was the most followed regulatory pathway in the artificial pancreas pipeline market as of September 2024?
As of September 2024, PMA was the most followed pathway for pipeline products in the artificial pancreas market.
-
Which are the major companies operating in the artificial pancreas pipeline market?
A few of the key companies associated with the artificial pancreas pipeline market are Admetsys Corp, Advanced Biosensors-Ohio LLC, AiTA Bio Inc, Beta-O2 Technologies Ltd, and Bigfoot Biomedical Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745


